Trial Profile
A phase IV, prospective, observational study of TNKase in patients enrolled in the national registry of myocardial infarction 4 and 5 (POST)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Tenecteplase (Primary)
- Indications Embolism and thrombosis; Myocardial infarction
- Focus Therapeutic Use
- Acronyms POST
- Sponsors Genentech
- 20 May 2008 New trial record.